Cargando…

Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020

We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadri, Sameer S, Demirkale, Cumhur Y, Sun, Junfeng, Busch, Lindsay M, Strich, Jeffrey R, Rosenthal, Ning, Warner, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798707/ https://www.ncbi.nlm.nih.gov/pubmed/33556157 http://dx.doi.org/10.1093/ofid/ofaa616

Ejemplares similares

Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study
por: Strich, Jeffrey R, et al.
Publicado: (2020)

2251. Estimating the Need for Novel Gram-Negative Active Antibiotics in US Hospitals
por: Strich, Jeffrey R, et al.
Publicado: (2019)

272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020
por: Lawandi, Alexander, et al.
Publicado: (2022)

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021
por: Lawandi, Alexander, et al.
Publicado: (2021)

1333. Utility of Admission Procalcitonin Level in Patients Presenting to the Hospital with Bloodstream Infection: Real-World Evidence from 250 US Hospitals
por: Kadri, Sameer S, et al.
Publicado: (2019)

1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards
por: Strich, Jeffrey R, et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020
por: Thomas-Rüddel, D., et al.
Publicado: (2020)

Excess Mortality in California During the Coronavirus Disease 2019 Pandemic, March to August 2020
por: Chen, Yea-Hung, et al.
Publicado: (2020)

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020
por: Kotwa, Jonathon D, et al.
Publicado: (2021)

Coronavirus Disease 2019: A Gastroenterologist’s Perspective in May 2020
por: Ahmed, Monjur
Publicado: (2020)

Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020)

Epidemiological Trends of Coronavirus Disease 2019 in Sierra Leone From March 2020 to October 2021
por: Liu, Zhiguo, et al.
Publicado: (2022)

Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020
por: Tenforde, Mark W., et al.
Publicado: (2020)

Cultural Collisions Vienna 2019/2020 - Vernissage & Workshops March 2020
por: Hoch, Michael
Publicado: (2020)

Topological network based drug repurposing for coronavirus 2019
por: Habibi, Mahnaz, et al.
Publicado: (2021)

Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020
por: Panepinto, Julie A., et al.
Publicado: (2020)

Coronavirus Disease Contact Tracing Outcomes and Cost, Salt Lake County, Utah, USA, March–May 2020
por: Fields, Victoria L., et al.
Publicado: (2021)

Surge in Incidence and Coronavirus Disease 2019 Hospital Risk of Death, United States, September 2020 to March 2021
por: Patel, Bela, et al.
Publicado: (2022)

Trends in Clinical Severity of Hospitalized Patients With Coronavirus Disease 2019—Premier Hospital Dataset, April 2020–April 2021
por: Whitfield, Geoffrey P, et al.
Publicado: (2021)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020
Publicado: (2020)

Thromboprophylaxis for medical inpatients with coronavirus disease 2019
por: Dalager-Pedersen, M., et al.
Publicado: (2020)

Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8–11 March 2020, Boston, USA
por: Psomas, Christina K, et al.
Publicado: (2020)

Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020
por: Lane, Morgan A, et al.
Publicado: (2021)

Effects of Coronavirus Disease (COVID-19) Related Contact Restrictions in Germany, March to May 2020, on the Mobility and Relation to Infection Patterns
por: Bönisch, Sebastian, et al.
Publicado: (2020)

Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Homeless Shelters in Chicago, Illinois—March–May, 2020
por: Ghinai, Isaac, et al.
Publicado: (2020)

World TB Day — March 24, 2020
Publicado: (2020)

Nightlife clusters of coronavirus disease in Tokyo between March and April 2020
por: Takaya, S., et al.
Publicado: (2020)

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
por: Bialek, Stephanie, et al.
Publicado: (2020)

Direct and Indirect Effects of the Coronavirus Disease 2019 Pandemic on Private Healthcare Utilization in South Africa, March 2020–September 2021
por: Perofsky, Amanda C, et al.
Publicado: (2022)

Epidemiology of coronavirus disease 2019 (COVD-19) outbreak cases in Oyo State South West Nigeria, March-April 2020
por: Usman, Aishat Bukola, et al.
Publicado: (2020)

Early estimation of the epidemiological parameters of novel coronavirus disease (COVID-2019) outbreak in Iran: 19 Feb-15 March, 2020
por: Olfatifar, Meysam, et al.
Publicado: (2020)

Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020*
por: Dennis, John M., et al.
Publicado: (2020)

Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020
por: Stokes, Erin K., et al.
Publicado: (2020)

Coronavirus disease 2019 pandemic in Greece, February 26 – May 3, 2020: The first wave
por: Maltezou, Helena C., et al.
Publicado: (2021)

Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, March 2016–March 2019
por: Alzahrani, Abdullah, et al.
Publicado: (2020)

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
por: Garg, Shikha, et al.
Publicado: (2020)

Length of Stay in ICU of Covid-19 patients in England, March - May 2020
por: Shryane, Nick, et al.
Publicado: (2021)

Pandemic March: 2019 Coronavirus Disease’s First Wave Circumnavigates the Globe
por: Shultz, James M., et al.
Publicado: (2020)

World TB Day — March 24, 2019
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c9rjotip4gqmi5k0j24k7tmp9m